Hypertriglyceridemia
📧 Sign up to get email alerts when something new happens for Hypertriglyceridemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-09-19FDA Approved: OMEGA-3-ACID ETHYL ESTERS — Original Application (Strides Pharma Science Limited)
FDA approved the original application for Omega-3-acid ethyl esters from Strides Pharma Science Limited, a generic prescription therapy used…
-
FDA approval · 2017-09-11FDA Approved: FENOFIBRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for fenofibrate from Lupin Pharmaceuticals, Inc., signaling an approved modification to the existing…
-
FDA approval · 2017-09-11FDA Approved: GEMFIBROZIL — Supplemental Application (Cadila Pharmaceuticals Limited)
The FDA approved a supplemental application for Gemfibrozil filed by Cadila Pharmaceuticals Limited.
-
FDA approval · 2017-09-07FDA Approved: FENOFIBRATE — Original Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical Industries, Inc.'s original ANDA for fenofibrate (generic fenofibrate).
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: Carbohydrate Metabolism Disorder Frequency in Hypertriglyceridemia Induced by Bexarotene of Cutaneous T Cell Lymphoma [Phase 4]
Phase 4 trial update reporting how often carbohydrate metabolism disorders occur in bexarotene-induced hypertriglyceridemia associated with …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-05-12FDA Approved: FENOFIBRIC ACID — Original Application (Alembic Pharmaceuticals Limited)
FDA approved an original application for a generic fenofibric acid product manufactured by Alembic Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Lovaza® and Microvascular Function in Type 2 Diabetes [Phase 4]
Phase 4 clinical trial update of Lovaza (omega-3-acid ethyl esters) assessing microvascular function in adults with type 2 diabetes and hype…
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: Genetic Effect on Omega 3 Fatty Acids for the Treatment of Fatty Liver Disease [NA]
A completed Yale University clinical trial investigated the genetic influence on omega-3 fatty acids for treating nonalcoholic fatty liver d…
-
FDA approval · 2017-04-07FDA Approved: FENOFIBRATE — Original Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved Glenmark's original application for Fenofibrate (generic), a lipid-lowering drug for hyperlipidemia, hypertriglyceridemia, …
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: Evaluation of Efficacy and Safety of Combined Omacor (Omega-3-acid Ethyl Esters) and Simvastatin Therapy in Hypertriglyceridemic Subjects [Phase 3]
Phase 3 trial evaluating efficacy and safety of combined omega-3-acid ethyl esters (Omacor) and simvastatin in adults with hypertriglyceride…
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Fat Tolerance From Lipid Emulsion Infusion Packaged in Glass or Plastic [NA]
A terminated clinical trial evaluating fat tolerance from lipid emulsion infusion when packaged in glass or plastic.
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Supplementation With Omega-3: Mechanism of Action [Phase 2]
Phase 2 study exploring the mechanism of action of omega-3 fatty acid supplementation for hypertriglyceridemia. The trial status is terminat…
-
CLINICAL_TRIALS trial_result · 2017-01-20Clinical Trial Update: Evaluate the Efficacy and Safety of KI1107 in Patients Whose TG Level is Not Adequately Controlled With Rosuvastatin Calcium Monotherapy While LDL-C is Properly Controlled [Phase 3]
Phase 3 trial assessing the efficacy and safety of KI1107 in patients with dyslipidemias whose triglycerides are not adequately controlled w…
-
FDA approval · 2016-12-15FDA Approved: FENOFIBRATE — Original Application (Cipla USA Inc.)
This FDA entry records Cipla USA Inc.'s original approval of a generic fenofibrate tablet for lipid disorders.
-
FDA approval · 2016-11-29FDA Approved: FENOFIBRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin Pharmaceuticals' supplemental application for fenofibrate, indicating an approved labeling update or new indication under…
-
CLINICAL_TRIALS withdrawal · 2016-11-25Clinical Trial Update: The Efficacy of EPA+DHA (SC401B) for Lowering Triglyceride Levels (≥ 500 mg/dL) [Phase 3]
A Phase 3 trial of EPA+DHA (SC401B) for lowering triglycerides in severe hypertriglyceridemia has been withdrawn.
-
FDA approval · 2016-11-09FDA Approved: FENOFIBRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for fenofibrate filed by Lupin Pharmaceuticals, Inc. under NDA 021695. The approval updates the feno…
-
CLINICAL_TRIALS trial_result · 2016-10-27Clinical Trial Update: Effects of Amino Acids on Regional Lipid Metabolism [NA]
A completed clinical trial evaluated the effects of amino acids on regional lipid metabolism in individuals with hypertriglyceridemia.
-
CLINICAL_TRIALS trial_result · 2016-10-21Clinical Trial Update: Omega-3 Fatty Acid Supplementation in Children [Phase 2]
Phase 2 study of omega-3 fatty acid supplementation in children with chronic kidney disease and hypertriglyceridemia has completed.
-
FDA approval · 2016-10-03FDA Approved: GEMFIBROZIL — Supplemental Application (NorthStar Rx LLC)
FDA approves a supplemental application for Gemfibrozil from NorthStar Rx LLC under an approved ANDA.
-
FDA approval · 2016-10-03FDA Approved: GEMFIBROZIL — Supplemental Application (Chartwell RX, LLC)
This document indicates FDA approval of a supplemental ANDA for Gemfibrozil from Chartwell RX, LLC.
-
CLINICAL_TRIALS research · 2016-09-29Clinical Trial Update: Intestines and Liver Contribution to Fasting Postprandial Hypertriglyceridemia [NA]
A completed ClinicalTrials.gov study investigating the roles of the intestines and liver in fasting postprandial triglyceride levels in indi…
-
CLINICAL_TRIALS trial_result · 2016-09-20Clinical Trial Update: Efficacy of TAK-085 in Participants With Hypertriglyceridemia [Phase 3]
A Phase 3 trial evaluated the efficacy of TAK-085 in hypertriglyceridemia, and the efficacy results have been posted for a completed study.
-
CLINICAL_TRIALS trial_result · 2016-09-20Clinical Trial Update: Long-term Efficacy and Safety Study of TAK-085 in Participants With Hypertriglyceridemia [Phase 3]
Phase 3 long-term efficacy and safety results for TAK-085 in participants with hypertriglyceridemia have been reported.
-
FDA approval · 2016-09-07FDA Approved: FENOFIBRIC ACID — Original Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved Amneal Pharmaceuticals of New York LLC's fenofibric acid under an original ANDA for treatment of lipid disorders including …